HB0056

· Shanghai Huaota Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB0056, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants [Phase 1]